Академический Документы
Профессиональный Документы
Культура Документы
com
AbstractLipase mediated DKR followed by a chemical and an enzymatic hydrolytic step were combined for the synthesis of enantiopure L -benzofuranyl- and L -benzothienyl alanines.
2008 Elsevier Ltd. All rights reserved.
1. Introduction
Both naturally occurring and unnatural a-arylalanines are
frequent constituents of biological and pharmaceutical
products. Several non-proteinogenic aminoacids as L Dopa, L -homophenylalanine or D -2-naphthylalanine are
already important pharmaceuticals,1 while others such as
D -phenylglycine, D -para-hydroxy-phenylglycine, and 2-thienyl-alanine are useful for the synthesis of certain drugs.2
Many others serve as building blocks for modern drug discovery research.3 The enantioselective synthesis of amino
acids is an attractive goal. While L -natural aminoacids
are obtained by fermentation or by applying natural enzymatic systems, for enantiopure unnatural aminoacid synthesis, chiral chemical catalysts or biocatalysts must be
used. The use of ammonia lyases4,5 or oxidoreductases1
for the enantioselective asymmetrization of prochiral substrates provides the desired enantiopure amino acids with
100% theoretical yield. However, their use for biocatalysis
is rather limited, as they show not only a strict reaction and
enantioselectivity but are also specic for one or a few substrates. Therefore, enzymes with broad substrate selectivity, while maintaining other selectivities are the preferred
biocatalysts. Hydrolases (acylases,6 amidases7 and hydantoinases, esterases,8 nitrilases or nitrilhydratases9) full
these criteria and by kinetic resolution of dierent kinds
of racemic substrates are the most important biocatalysts
for enantioselective aminoacid synthesis. The main draw-
* Corresponding author. Tel.: +40 264 593833; fax: +40 264 590818;
e-mail: irimie@chem.ubbcluj.ro
0957-4166/$ - see front matter 2008 Elsevier Ltd. All rights reserved.
doi:10.1016/j.tetasy.2008.01.031
I
O
501
II
S
4a
O
4b
III
IV
OH
O
O
VI
OH
4c
Cl
VII
S
S
6d
Scheme 1. Synthesis of heteroaryl aldehydes. Reagents and conditions: (I) POCl3/DMF; (II) (1) BuLi, 78 C, 1 h, (2) DMF, 10 C, 2 h; (III)
ClCH2COOEt, K2CO3/acetone; (IV) K2CO3/H2O; (V) Ac2O/AcONa+; (VI) SeO2/dioxane, reux; (VII) CH2O/HCl, 60 C.
502
OH
Cl
II
5a-c
IV
COOEt
4a-c
EtOOC
III
NHCOCH3
7a-d
6a-c
COOAlk
S
b
O
c
COOH
NHCOCH3
8a-d
VI
R
O
HOOC
R
NHCOCH3
rac-10a-d
O
R
COOH
VII
R
NHCOCH3
rac-9a-d
rac-11a-d
COOH
R
VIII
NH2
rac-12a-d
Scheme 2. Synthesis of racemic heteroaryl alanines and their derivatives. Reagents and conditions: (I) NaBH4/CH3OH; (II) SOCl2, benzotriazole/CH2Cl2;
(III) NaH, CH3CONHCH(COOEt)2/DMF, 60 C; (IV) 10% KOH, 20 h; (V) toluene/xylene, reux, 2 h; (VI) alcohol, CDI/THF; (VII) DCC/CH2Cl2;
(VIII) 18% HCl, reux, 4 h.
O
O
O
N
S
O
NHCOCH3
O
NHCOCH3
O
O
N
S
O
O
NHCOCH3
O
NHCOCH3
Figure 1. (a) Elution diagram of the mixture of the racemic starting material rac-11d and racemic product rac-10d for the lipase catalysed DKR.
(b) Elution diagram for the enzymatic DKR of rac-4-((benzo[b]thiophen-3-yl)methyl)-2-methyloxazol-5(4H)-one rac-11d: after 2 h (blue trace), after 24 h
(red trace) and after 48 h (green trace).
a
b
Entry
Type of ester
1
2
3
4
Methyl ester
Ethyl ester
Propyl ester
Butyl ester
L -10b
L -10c
L -10d
3
67
71
67
3
65
71
69
3
65
69
67
3
73
79
75
In neat alcohol.
Total conversion after 6 h.
Entry
Solvent
1
2
3
4
5
6
Dioxane
Dichloromethane
Toluene
Acetonitrile
Tetrahydrofuran
Diethylether
COOH
Acylase I
NHCOCH3
L -10c
L -10d
79
37
59
55
47
71
83
42
69
73
81
59
86
54
79
83
83
73
COOH
NH2
pH 7-8
COOH
+
R
NHCOCH3
L-12a-d
D-9a-d
O
II
L -10a
75
39
69
61
71
67
(rac)-9a-d
O
D-11a-d
503
O
N
O
c
III
COOH
R
NHCOCH3
(rac)-11a-d
COOPr
R
NHCOCH3
L-9a-d (ee 81-87%)
IV
O
R
O
N
L-11a-d
Lipase
Alcohol
COOAlk
R
COOH
R
NHCOCH3
L-10a-d
NHCOCH3
(rac)-9a-d
COOH
R
NH2
L-12a-d (ee>99%)
Scheme 3. Enantioselective synthesis of L -heteroaryl alanines and their derivatives: (a) DKR of the lipase mediated alcoholysis of oxazolones rac-11ad;
(b) enantiomer selective hydrolysis of rac-9ad; (c) chemoenzymatic synthesis of enantiopure L -12ad. Reagents and conditions: (I) DCC/CH2Cl2; (II)
propanol, Novozyme 435/dioxane; (III) Na2CO3, H2O, reux; (IV) Acylase I, pH 78.
Starting from the enantiomerically enriched L -2-acetamido-3-(heteroaryl)propanoic acids propyl esters L -10a
d, a second chiral selector had to be used in one of the next
two hydrolytic steps, to obtain enantiopure L -2-amino-3(heteroaryl)propanoic acids. Acylase I proved to be a
stereospecic catalyst for the kinetic resolution of racemic
2-acetamido-3-(heteroaryl)propanoic
acids
rac-9ad
(Scheme 3b). Enantiopure L -heteroaryl-amino acids
L -12ad and D -heteroaryl-N-acetyl-amino-acids D -9ad
were isolated from the reaction mixture.
With these results in hand, the preparative scale synthesis
of the enantiopure L -12ad from racemic 2-acetamido-3(heteroaryl)propanoic acids rac-9ad was set up (Scheme
3c).
The progress of the reaction was monitored after each step
by HPLC to determine the enantiopurity of the isolated
compounds and the conditions for quantitative conversions. The lipase mediated DKR was stopped when the
consumption of the rac-4-((heteroaryl)methyl)-2-methyloxazol 5(4H)-ones rac-11ad ceased. The ee of the isolated products was the same as the one found in the case
of small scale reactions. Then, by the chemical hydrolysis,
without altering the ee (Fig. 2), the enantiomer enriched
L -2-acetamido-3-(heteroaryl)propanoic acid propyl esters
L -10ad were transformed in good yields (98%)
into L -2-acetamido-3-(heteroaryl)-propanoic acids L -9ad.
After the enantiospecic Acylase I mediated hydrolysis of
the latest compounds, the enantiopure nal products,
L -heteroarylalanines L -12ad were easily isolated on an
ion-exchange column. The yields and the specic rotation
values of the isolated nal products are shown in
Table 3.
Besides the yields, which varied between 76% and 85%, the
absolute congurations and the enantiomeric purity of the
isolated heteroarylalanines were also determined. Figure 3
shows the elution diagram on a chiral column of the
L -2-amino-3-(benzo[b]thiophene-3-yl)propanoic acid L -12d
(red trace) produced and that of the racemic 2-amino3-(benzo[b]thiophene-3-yl)propanoic acid rac-12d (blue
trace) as a control.
mAU
250
200
150
COOH
100
COOH
NHCOCH3
NHCOCH3
50
0
13.6
decreased the enantioselectivity of the global transformation. A high nucleophilesubstrate ratio (310) also decreased the stereoselectivity of the lipase mediated
reaction. It was found that 2 equiv of the nucleophile was
the optimal amount necessary for total conversion of
rac-4-((heteroaryl)methyl)-2-methyloxazol-5(4H)-ones rac11ad (Fig. 1b, green trace), while the concurrent
non-enzymatic alcoholysis decreased the ee when the
substrateenzyme ratio was higher than 1:1 (m/m). These
results are in good agreement with our previous observation concerning the non-enzymatic alcoholysis of
the rac-4-((heteroaryl)methyl)-2-methyloxazol-5(4H)-ones.
It was found that in neat alcohols rac-4-((heteroaryl)methyl)-2-methyloxazol-5(4H)-ones rac-11ad were totally
transformed into racemic products in about 1 day, while
using triethylamine as a catalyst (0.25 equiv) total conversion of the substrate occurs in 56 h.
3.1
504
10
12
14
16
min
3. Conclusions
The present work describes the usability of a chemoenzymatic procedure for the preparation of enantiopure
heteroaryl alanines starting from racemic 2-acetamido-3(hetero- aryl)propanoic acids. The rst enzyme catalyzed
step was the Novozyme 435 mediated dynamic kinetic resolution of the oxazolones which provided the N- and Cprotected L -amino acids (ee 7685%) with theoretical 100%
yield. The protecting groups were removed with excellent
yields by combining a second chemical (mild hydrolysis
of the ester group) and a third enzymatic step (hydrolysis
of the amide group). The latest, due to the L -specicity of
Acylase I, raised the ee of the nal product to more than
99%.
4. Experimental
4.1. Analytical methods
The 1H and 13C NMR spectra were recorded on a Bruker
spectrometer operating at 300 MHz and 75 MHz, respectively, at 25 C. Electron impact mass spectra (EI-MS)
were taken on a VG 7070E mass spectrometer operating
at 70 eV.
High performance liquid chromatography (HPLC) analyses were conducted with a HP 1200 instrument using an
Astec Chirobiotic-Tag column (4.6 250 mm) and a mixture of methanol and TEAA-buer (pH 4.1), 80:20 (v/v)
as eluent for the enantiomeric separation of rac-9,12ad
and a Chiralpak IA column (4.6 250 mm) and a mixture
of hexane and 2-propanol, 90:10 (v/v) as eluent for enantiomeric separation of rac-1011ad, both at 1 mL/min
ow rate. For all chiral compounds, high resolution enantiomeric separation was performed. Retention times for L and D -912ad are presented in Table 4.
505
Table 3. Yields and specic rotations for the isolated enantiopure L -amino acids L -12ad
Substrate
Producta
Yieldb (%)
1
a20
D (10 mg mL )
rac-9a
rac-9b
rac-9c
rac-9d
L -12a
76
79
83
85
L -12b
L -12c
L -12d
10.3
mAU
600
500
400
COOH
300
COOH
NH2
NH2
16.2
200
100
0
2.5
7.5
10
12.5
15
17.5
20 min
Figure 3. Elution diagram of the isolated enantiopure L -2-amino-3(benzo[b]thiophene-3-yl)propanoic acid L -12d (red trace) and rac-2amino-3-(benzo[b]thiophene-3-yl)propanoic acid rac-12d as reference
(blue trace).
D -9a
L -9b
D -9b
L -9c
D -9c
L -9d
D -9d
2.8
11.6
2.9
8.7
2.8
11.0
3.0
13.1
D -10b
L -10b
D -10c
D -10a
a
12.5
10.4b
10.6c
9.5d
L -10a
a
14.4
12.2b
12.6c
11.0d
12.0
9.3b
11.5c
10.2d
11a
8.9
L -12a
8.8
13.6
12.3b
15.8c
13.2d
8.1
11.2b
11.5c
11.2d
11b
12.3
11.3
L -10c
a
10.9
12.9b
13.0c
12.9d
D -10d
a
12.0
10.5b
10.7c
9.4d
11c
11.5
D -12a
L -12b
D -12b
14.9
10.1
15.2
7.5
L -12c
8.9
L -10d
15.0a
13.5b
14.0c
11.8d
11d
8.1
8.2
9.0
D -12c
L -12d
D -12d
13.5
10.5
15.7
Methyl ester.
Ethyl ester.
c
Propyl ester.
d
Butyl ester.
b
Benzofuran, benzo[b]thiophene, 1-(2-hydroxyphenyl)-ethanone, ethyl 2-chloroacetate, all inorganic reagents and solvents were produced from Aldrich or Fluka. All solvents
were puried and dried by standard methods as required.
Lipases AY, AK, PS and F were from Amano, Europe,
England. Lipases from Candida rugosa (CrL), Candida
cylindracea (CcL) and Acylase I were purchased from
Fluka. Lipase B (CAL-B, Novozyme 435) from Candida
antarctica and Lypozyme TL IM were purchased from
Novozymes, Denmark.
4.3. Chemical synthesis of racemic heteroaryl alanines and
their derivatives
4.3.1. Synthesis of benzofuran-2-carbaldehyde 4a. Phosphoryl trichloride (132 g, 80 mL, 0.86 mol) was added in
small portions with slight warming into a solution of benzofuran (92 g, 0.78 mol) in anhydrous dimethylformamide
(150 g, 158 mL, 2.05 mol). The mixture was heated for
10 h at 100 C, then cooled to room temperature and treated with an extra portion of dimethylformamide (50 g,
52.7 mL, 0.68 mol) and phosphoryl trichloride (40 g,
24.3 mL, 0.26 mol). The mixture was heated for another
10 h. The cooled mixture was treated with saturated
sodium acetate solution in water until the pH rose to 6.
The organic compounds were extracted with Et2O
(3 100 mL). The combined organic layers were washed
with saturated KHCO3 solution (3 50 mL) and water
(100 mL), and nally dried over anhydrous MgSO4. The
solvent was removed and the residue distilled in vacuo.
Yield = 62%; bp 135136 C/18 mmHg (135136 C/
18 mmHg15); HRMS: M+ found (M+ calculated for
C9H6O2): 146.03701 (146.03678); MS: m/z (%) = 148
(1.53, M+2), 147 (19.73, M+1), 146 (100, M), 145
(87.96), 138 (0.44), 131 (0.36), 121 (0.29), 120 (0.71), 119
(1.18), 118 (15.48), 117 (0.68), 116 (0.39), 102 (0.40), 101
(1.13), 98 (0.33), 92 (0.64); 1H NMR (CDCl3): d = 7.24
7.28 (m, 1H), 7.427.46 (m, 1H), 7.51 (s, 1H), 7.52 (d,
1H), 7.67 (d, 1H), 9.79 (s, 1H); 13C NMR (CDCl3):
d = 112.7, 117.9, 123.7, 124.2, 126.7, 129.3, 152.7, 156.3,
179.8.
4.3.2. Synthesis of benzo[b]thiophene-2-carbaldehyde
4b. Into a cooled solution (78 C) of benzo[b]thiophene
(3.24 g, 2.17 mL, 20 mmol) in anhydrous THF (120 mL),
2.7 M n-BuLi in heptane (8.15 mL, 1.1 equiv) was added
dropwise under nitrogen, and the mixture was stirred for
1 h at 78 C. Then, anhydrous DMF (4.38 g, 4.62 mL,
60 mmol) was added and the solution was stirred for 2 h
506
while warming the reaction mixture to 10 C. The mixture was hydrolyzed with saturated NH4Cl solution
(30 mL) and diluted with water (100 mL). After the separation of the phases, the water phase was extracted with Et2O
(3 50 mL). The combined organic layers were washed
with water and brine, dried over anhydrous MgSO4 and
concentrated in vacuo. The crude product was puried by
column chromatography on silica gel using dichloromethane as eluent. Yield = 62%; mp 3435 C from ethanol
(3434.3 C from ethanol16) HRMS: M+ found (M+ calculated for C9H6OS): 162.01418 (162.01394); MS: m/z
(%) = 164 (15.42, M+2), 163 (56.40, M+1), 162 (100, M),
161 (97.75), 147 (0.89), 136 (2.06), 135 (6.49), 134 (58.68),
133 (61.29), 132 (5.52), 108 (5.84), 107 (1.25), 106 (3.02),
105 (1.69), 102 (2.94), 98 (1.58); 1H NMR (CDCl3):
d = 7.347.43 (m, 1H), 7.43745 (m, 1H), 7.82 (d, 1H),
7.87 (d, 1H), 7.95 (s, 1H), 10.03 (s, 1H); 13C NMR
(CDCl3): d = 122.3, 124.3, 125.3, 127.2, 133.5, 137.5,
141.7, 142.3, 183.7.
4.3.3. Synthesis of (2-acetyl-phenoxy)acetic acid ethyl ester
1. A mixture of 1-(2-hydroxyphenyl)ethanone (110 g,
97.26 mL, 0.80 mol), ethyl 2-chloroacetate (122.5 g,
107 mL, 1.0 mol) and anhydrous K2CO3 (110.5 g,
0.80 mol) in acetone (600 mL) was reuxed for 58 h. After
cooling, the precipitate was ltered o and washed with
acetone (3 150 mL). The acetone was removed by distillation from the combined solutions and the crude product
was distilled under reduced pressure aording 1. Yield:
58%, bp 185 C/5 mmHg (185 C/5 mmHg17); HRMS:
M+ found (M+ calculated for C12H14O4): 222.08889
(222.08921); MS: m/z (%) = 224 (1.14, M+2), 223 (9.67,
M+1), 222 (85.33, M), 208 (3.89), 207 (39.67), 204 (1.15),
193 (1.26), 180 (1.72), 179 (9.33), 177 (1.70), 176 (2.98),
153 (1.19), 152 (5.68), 151 (85.63), 150 (8.08), 149 (100),
148 (12.94), 147 (1.40), 137 (0.84), 136 (1.78), 135 (6.10),
134 (1.48), 133 (5.88), 132 (1.10), 131 (5.12), 124 (0.76),
123 (9.80), 122 (4.17), 121 (62.24), 120 (7.44), 119 (1.31),
118 (1.25), 107 (5.43), 106 (2.13), 105 (26.11), 104 (1.70),
103 (1.91), 101 (3.35), 95 (1.13); 1H NMR (CDCl3):
d = 1.23 (t, 3H), 2.65 (s, 3H), 4.21 (q, 2H), 4.65 (s, 2H),
6.75 (d, 1H), 66.99 (m, 1H), 7.357.39 (m, 1H), 7.69 (d,
1H); 13C NMR (CDCl3): d = 13.1, 31.0, 60.5, 64.3, 111.2,
120.7, 127.8, 129.7, 132.5, 155.9, 167.1, 198.7.
4.3.4. Synthesis of (2-acetyl-phenoxy)acetic acid 2. Into
the vigorously stirred solution of sodium carbonate (53 g,
0.50 mol) in water (800 mL), (2-acetyl-phenoxy)acetic acid
ethyl ester (100 g, 0.45 mol) was added and the mixture was
gently reuxed. After 1 h of heating the solution was
cooled to 5 C and acidied carefully with concentrated
HCl solution. The deposited precipitate was ltered o,
washed several times with cold water. Yield = 97%; mp
115 C from water (114114.3 C from water16); HRMS:
M+ found (M+ calculated for C10H10O4): 194.05708
(194.05791); MS: m/z (%) = 195 (1.42, M+1), 194 (12.32,
M), 180 (0.76), 179 (7.63), 176 (0.92), 153 (5.12), 152
(2.66), 151 (25.10), 150 (33.02), 149 (6.50), 148 (6.88), 137
(1.06), 136 (11.71), 135 (56.58), 134 (1.45), 133 (7.52), 132
(3.50), 131 (2.83), 124 (0.89), 123 (8.21), 122 (7.53), 121
(100), 120 (4.40), 119 (0.84), 118 (1.01), 108 (1.58), 107
(10.66), 106 (3.26), 105 (18.51), 104 (2.74), 103 (1.26), 95
507
508
4.3.10.4.
rac-2-Acetamido-3-(benzo[b]thiophen-3-yl)propanoic acid rac-9d. Yield = 85%; mp 154 C from toluene (153 C from benzenepetroleum ether14); HRMS:
M+ found (M+ calculated for C13H13NO3S): 263.06180
(263.06161); MS: m/z (%) = 263 (22.57, M), 206 (5.38),
205 (9.72), 204 (80.60), 195 (3.92), 191 (4.19), 181 (4.36),
176 (4.69), 175 (4.37), 167 (5.28), 165 (4.75), 163 (4.22),
162 (7.43), 161 (4.47), 160 (4.29), 153 (7.79), 151 (6.44),
149 (10.58), 148 (10.67), 147 (100.00), 141 (4.07), 139
(4.49), 137 (7.13), 136 (4.06), 135 (4.72), 134 (4.88), 127
(4.87), 126 (4.02), 125 (10.91), 124 (4.15), 123 (8.97), 121
(4.98), 115 (7.52), 113 (5.17), 112 (4.43), 111 (16.32), 110
(5.23), 109 (11.35), 107 (4.75), 103 (4.43), 99 (6.05); 1H
NMR (DMSO-d6): d = 1.75 (s, 3H), 3.363.40 (m, 2H),
4.384.41 (m, 1H), 7.327.35 (m, 2H), 7.39 (s, 1H), 7.82
(d, 1H), 7.91 (d, 1H); 13C NMR (DMSO-d6): d = 22.7,
30.9, 53.9, 121.7, 122.6, 122.8, 123.8, 123.9, 133.6, 139.2,
139.3, 168.7, 175.5.
4.3.11. Synthesis of rac-propyl 2-acetamido-3-(heteroaryl)propanoates rac-10ad. Into a solution of carbonyldiimidazole (90 mg, 0.55 mmol) and rac-2-acetamido3-(heteroaryl)propanoic acid rac-9ad (0.5 mmol) in
anhydrous THF (2.5 mL), 1-propanol (45 mg, 56 lL, 0.75
mmol) was added in one portion at room temperature.
After the reaction was complete (checked by TLC), the solvent was distilled o in vacuo and the crude product was
puried with column chromatography on silica gel using
as eluent dichloromethaneacetone 90:10 (v/v). Methyl,
ethyl and butyl 2-acetamido-3-(heteroaryl)propanoates
were prepared in the same manner.
4.3.11.1. rac-Propyl 2-acetamido-3-(benzofuran-2-yl)propanoate rac-10a. Yield = 89%; semisolid, HRMS:
M+ found (M+ calculated for C16H19NO4): 289.13163
(289.13141); MS: m/z (%) = 291 (1.8, M+2), 290 (18,
M+1), 289 (100, M), 288 (17), 287 (12), 284 (11.5), 279
(20.5), 278 (20.5), 268 (11.3), 264 (20.8), 258 (27.1), 257
(15.2), 248 (58.4), 242 (17.3), 231 (18.5), 229 (12.4), 225
(12.7), 215 (12.3), 212 (13.6), 209 (14.9), 193 (22.1), 176
(12.2), 159 (20.1), 129 (14.6); 1H NMR (CDCl3): d = 0.92
(t, 3H), 1.601.74 (m, 2H), 1.99 (s, 3H), 3.33 (d, 2H),
4.054.18 (m, 2H), 4.924.98 (m, 1H), 6.47 (1H, NH),
6.49 (s,1H), 7.167.26 (m, 2H), 7.39 (d, 1H), 7.49 (d, 1H);
13
C NMR (CDCl3): d = 10.3, 21.8, 23.0, 31.0, 51.2, 67.4,
104.9, 110.8, 120.6, 122.7, 123.8, 128.3, 153.5, 154.9,
170.0, 171.2.
4.3.11.2. rac-Propyl 2-acetamido-3-(benzo[b]-thiophen-2yl)propanoate rac-10b. Yield = 88%; semisolid, HRMS:
M+ found (M+ calculated for C16H19NO3S): 305.10796
(305.10856); MS: m/z (%) = 307 (9.8, M+2), 306 (23.1,
M+1), 305 (100, M), 304 (32.9), 303 (31.6), 302 (13.9),
301 (14.0), 300 (35.6), 290 (64.1), 289 (69.6), 288 (33.4),
287 (36.8), 286 (39.1), 285 (16.2), 275 (20.1), 271 (17.4),
270 (70.4), 260 (16.6), 257 (15.4), 256 (26.7), 247 (16.6),
225 (24.4), 219 (15.2), 213 (23.5), 201 (8.9), 185 (11.3),
170(6.7), 144 (2.3), 127 (6.8); 1H NMR(300 MHz, CDCl3):
d = 0.94 (t, 3H), 1.631.74 (m, 2H), 2.03 (s, 3H), 3.383.52
(m, 2H), 4.12 (t, 2H), 4.924.98 (m, 1H), 6.43 (1H, NH),
7.01 (s, 1H), 7.257.35 (m, 2H), 7.69 (d, 1H), 7.76 (d,
1H); 13C NMR (75 MHz, CDCl3): d = 10.3, 21.8, 23.1,
509
510
suspended into a vigorously stirred solution of sodium carbonate (0.053 g, 5 mmol) in water (8 mL) and the mixture
was gently reuxed. After 2 h of heating, the solution was
cooled to 5 C and extracted with dichloromethane
(3 10 mL). The aqueous phase was then acidied carefully with concentrated HCl solution. The deposited precipitate was ltered o and washed several times with
cold water. The isolated L -2-acetamido-3-(heteroaryl)propanoic acid L -9ad was then dissolved in water (10 mL) by
adjusting the pH to 8 with LiOH solution (1.25 M). Then
Acylase I (22 units, 60 mg) and CoCl2 6H2O (50 mg
0.2 mmol) were added and the reaction mixture was stirred
at 37 C, while by the addition of LiOH solution (1.25 M),
the pH of the solution was kept between 7 and 8. After
completion of the L- 2-acetamido-3-(heteroaryl)-propanoic
acid L -9ad hydrolysis, the pH was adjusted to 1.5 with
5% HCl. The suspension formed was extracted with dichloromethane (3 10 mL). The aqueous phase was heated
with active charcoal (50 mg) to 90 C for 2 min, cooled at
room temperature, ltered and applied to a Dowex 50X8
cation exchange resin column. Elution of the pure L -enantiomers of the 2-amino-3-(heteroaryl)propanoic acids L 12ad occurred with 2 M ammonia solution.
Acknowledgements
Financial support from the Romanian Ministry of Education and Research (CEEX Contract No. 1480-6/
07.04.2006) is gratefully acknowledged.
References
1. Servi, S.; Tessaro, D.; Pedrocchi-Fantoni, G. Coord. Chem.
Rev., in press. doi:10.1016/j.ccr.2007.09.012.
2. Zaks, A.; Dodds, D. R. DDT 1997, 513532.
3. Schmid, A.; Dordick, J. S.; Hauer, B.; Kiener, A.; Wubbolts,
M.; Witholt, B. Nature 2001, 49, 258268.
4. (a) Poppe, L.; Retey, J. Angew. Chem. 2005, 117, 37343754;
(b) Poppe, L.; Retey, J. Angew. Chem., Int. Ed. 2005, 44,
36683688.
5. Paizs, C.; Katona, A.; Retey, J. Chem. Eur. J. 2006, 12, 2739
2744.
6. (a) Chenault, H. K.; Dahmer, J.; Whitesides, G. M. J. Am.
Chem. Soc. 1989, 111, 63546364; (b) Bommarius, A. S.;
Drauz, K.; Giinther, K.; Knaup, G.; Schwarm, M. Tetrahedron: Asymmetry 1997, 8, 31973200.
7. Yagasaki, M.; Ozaki, A. J. Mol. Catal. B: Enzym. 1998, 4, 1
11.
8. Chenm, S. T.; Huang, W. H.; Wang, K. T. Chirality 2004, 6,
572576.
9. Chaplin, J.; Levin, M.; Morgan, B.; Farid, N.; Li, J.; Zhu, Z.;
McQuaid, J.; Nicholson, L.; Rand, C.; Burk, M. Tetrahedron:
Asymmetry 2004, 15, 27932796.
10. Jersey, J.; Willadsen, P.; Zerner, B. Biochemistry 1969, 6,
19591967.
11. Brown, S.; Parker, M. C.; Turner, N. Tetrahedron: Asymmetry 2000, 11, 16871690.
12. Turner, N.; Winterman, J.; McCague, R.; Parratt, J.; Taylor,
S. Tetrahedron Lett. 1995, 36, 11131116.
13. Goodman, M.; Glaser, C. B. J. Org. Chem. 1970, 35, 1954
1962.
14. Kawakubo, H.; Tagaki, S.; Yamaura, Y.; Katoh, S.; Ishimoto, Y.; Nagatani, T.; Mochizuki, D.; Kamata, T.; Yasuharu,
S. J. Med. Chem. 1993, 36, 35263532.
15. Suu, V. T.; Buu-Hoi, N. P.; Xuong, N. D. Bull. Soc. Chim. Fr.
1962, 18751877.
16. David, A. S.; Morris, J. D. J. Am. Chem. Soc. 1952, 74, 2935.
17. Nielek, S.; Tadeusz, L. Chem. Ber. 1982, 115, 12471251.
18. Zaidlewicz, M.; Chechlowska, A.; Prewysz-Kwinto, A.;
Wojtczak, A. Heterocycles 2001, 55, 569577.
511
19. Blicke, F. F.; Sheets, D. G. J. Am. Chem. Soc. 1948, 70, 3768
3770.
20. Chapman, N. B.; Scrowston, R. M.; Westwood, R. J. Chem.
Soc. Perkin. Trans. 1 1969, 18551858.
21. Erlenmeyer, H.; Grubenmann, W. Helv. Chim. Acta 1947, 30,
297304.
22. Ried, W.; Bender, H. Chem. Ber. 1955, 88, 3438.
23. Avakian, S.; Moss, J.; Martin, G. J. J. Am. Chem. Soc. 1948,
70, 30753076.